KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Invested Capital (2016 - 2025)

Neogenomics (NEO) has disclosed Return on Invested Capital for 13 consecutive years, with 0.14% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 4.0% year-over-year to 0.14%, compared with a TTM value of 0.14% through Dec 2025, down 4.0%, and an annual FY2025 reading of 0.13%, down 3.0% over the prior year.
  • Return on Invested Capital was 0.14% for Q4 2025 at Neogenomics, up from 0.14% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.01% in Q1 2021 and bottomed at 0.15% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 0.11%, with a median of 0.11% recorded in 2022.
  • The sharpest move saw Return on Invested Capital dropped -12bps in 2022, then increased 5bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.06% in 2021, then tumbled by -142bps to 0.14% in 2022, then grew by 27bps to 0.1% in 2023, then increased by 4bps to 0.1% in 2024, then tumbled by -37bps to 0.14% in 2025.
  • Business Quant data shows Return on Invested Capital for NEO at 0.14% in Q4 2025, 0.14% in Q3 2025, and 0.13% in Q2 2025.